ONYX PHARMACEUTICALS - 683399109
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BANK OF MONTREAL /CAN/ | History | New | 28,359 | 3,537 | 0.01% | — | 1 | +28,359 | New | Q3 2013 | Jan 08, 2014 |
| DIAM Co., Ltd. | History | Reduced | 9,299 | 1,159 | 0.02% | 0.01% | 2 | -992 | -9.64% | Q3 2013 | Feb 05, 2014 |
| E. Ohman J:or Asset Management AB | History | No change | 1,900 | 236 | 0.06% | 0.05% | 3 | 0 | 0.0% | Q3 2013 | Apr 05, 2024 |
| FTB Advisors, Inc. | History | No change | 169 | 15 | 0.01% | 0.01% | 4 | 0 | 0.0% | Q2 2013 | Feb 25, 2014 |
| VICTORY CAPITAL MANAGEMENT INC | History | New | 31 | 3 | 0.0% | — | 5 | +31 | New | Q3 2013 | Mar 12, 2014 |